Page last updated: 2024-10-27

flumazenil and Macular Degeneration

flumazenil has been researched along with Macular Degeneration in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Macular Degeneration: Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Acar, N1
Merle, BMJ1
Ajana, S1
He, Z1
Grégoire, S1
Hejblum, BP1
Martine, L1
Buaud, B1
Bron, AM1
Creuzot-Garcher, CP1
Korobelnik, JF1
Berdeaux, O1
Jacqmin-Gadda, H1
Bretillon, L1
Delcourt, C1

Other Studies

1 other study available for flumazenil and Macular Degeneration

ArticleYear
Predicting the retinal content in omega-3 fatty acids for age-related macular-degeneration.
    Clinical and translational medicine, 2021, Volume: 11, Issue:7

    Topics: Aged; Aged, 80 and over; Case-Control Studies; Cholesterol Esters; Dietary Supplements; Discriminant

2021